February 25, 2025 February 25, 2025Categories News StoriesTop trial results of 2024: A year of significant advancements in cancer treatment by ECOG-ACRIN and PrECOG
February 25, 2025 February 25, 2025Categories Announcements News StoriesThe February 2025 News from ECOG-ACRIN blog is now available
February 14, 2025 February 14, 2025Categories News StoriesFrom the group co-chairs of ECOG-ACRIN: A perspective on indirect costs (requires subscription)
February 6, 2025 February 6, 2025Categories News Stories“I was delighted when I saw the results. Positive phase 3 trials in glioma are a rarity.” David Schiff on the results of E3F05
